Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT07594847 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

A Study of HDM1002 Tablets on Cardiac Repolarization in Healthy Subjects

StatusRecruiting
PhasePhase 1
Started
View on ClinicalTrials.gov ↗
Record status
This record was last updated May 19, 2026 (before its estimated September 25, 2026 completion). Its status may not reflect the trial's current state.

Record History

  1. Study First Submitted
The aim of this trial is to evaluate the effect of a single oral dose of HDM1002 tablets on the QT/QTc interval in healthy subjects.
Trial Details
NCT Number NCT07594847
Lead Sponsor Hangzhou Zhongmei Huadong Pharmaceutical Co., Ltd.
Conditions
(from sponsor)		 Healthy Adult Subject
Enrollment 72 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov